Moonbow 112 IX is a modern hybrid cannabis cultivar developed through the backcrossing of its parent strain, Moonbow. This specific selection process aimed to refine the genetic stability and trait expression of the original lineage, resulting in a plant that requires moderate cultivation experience. Thriving in both indoor and outdoor environments, the strain exhibits a high yield potential and completes its flowering cycle in 67 days.

The chemical profile of Moonbow 112 IX is complex, characterized primarily by limonene, followed by an intricate balance of linalool, caryophyllene, bisabolol, and humulene. The secondary constituent profile continues with beta-pinene, myrcene, pinene, nerolidol, and caryophyllene-oxide, trailing into notes of valencene, camphene, borneol, terpinolene, and ocimene. This diverse range of molecules contributes to a distinct aromatic and flavor signature dictated by the interplay of these fifteen specific terpenes.

As a THC-dominant hybrid with 19.5% THC, Moonbow 112 IX consistently produces effects reported as relaxed, happy, and uplifted. These properties make the strain a functional choice for users seeking support with stress, pain, and sleep-related concerns. The genetic significance of this cultivar is underscored by its status as a parent to several notable offspring, including Oishii, Zsunami, and Red Halo, marking its contribution to modern breeding programs.